BioSpace News Archive

Deals

Arbor Scores $215 Million for Next-Gen CRISPR Toolbox

Arbor announced an oversubscribed Series B raise totaling $215 million, a significant increase from their initial $15.6 milllion Series A round to test for liver and CNS diseases.

November 9, 2021
·
2 min read
·
Kate Goodwin
Drug Development

COVID News: Vaccinated Death Toll Much Lower, Moderna Gets Thumbs Down from France and More

New studies come out regularly supporting the efficacy and safety of the COVID-19 vaccines. Here’s a look as well as other COVID-19 news.

November 9, 2021
·
5 min read
·
Mark Terry
Policy

Oklahoma’s Highest Court Overturns Landmark Opioid Verdict Against J&J

The Oklahoma Supreme Court has overturned the landmark $465 million opioid verdict handed down against Johnson & Johnson in 2019.

November 9, 2021
·
2 min read
·
Heather McKenzie
Business

Biohaven Partners with Pfizer to Market Nurtec Migraine Medicine

Biohaven and Pfizer have partnered to market the Nurtec migraine medicine outside the U. S. once approved by global regulatory organizations. Here’s more about it.

November 9, 2021
·
3 min read
·
Alex Keown
Drug Development

New Data from Amgen Migraine Drug Aimovig Challenges the Status Quo

The study was momentous in that it was the first head-to-head comparison of two modalities. The Aimovig showed significantly good results and aced primary endpoints.

November 9, 2021
·
2 min read
·
Heather McKenzie
Policy

Legal Woes Keep Pouring in for Jailed “Pharma Bro”

Although Martin Shkreli continues to serve a prison sentence for fraud, the so-called “Pharma Bro” remains in legal hot water over antitrust charges.

November 9, 2021
·
3 min read
·
Alex Keown
Drug Development

AstraZeneca Will Unite Vaccines, Antibody Therapies in New Division

AstraZeneca announced its plans to create a new, separate division for vaccines and antibody therapies, specifically its COVID-19 vaccine developed with the University of Oxford and other COVID-19 antibody treatments.

November 9, 2021
·
3 min read
·
Mark Terry
Business

New Company Enters AI Space with $40 Million in Hand

DeepCure announced the closing of its $40 million Series A financing round. The round, led by Morningside Ventures, brings the company’s total amount raised to $47 million since it was founded in 2018.

November 9, 2021
·
2 min read
·
Ellen Camacho
Drug Development

Genuv’s Sungho Han Encourages Her Staff to Challenge the Status Quo

Sungho Han, Ph.D., founder and CEO of Genuv Inc. in Seoul, South Korea, has built her career and her company by thinking outside the box.

November 9, 2021
·
4 min read
·
Gail Dutton
Business

Novartis Walks Away from $2.6 Billion Xencor Collaboration

Shares of Xencor, Inc. are down nearly 6% after the company announced Novartis terminated its rights to develop vibecotamab, a CD123 x CD3 blood cancer bispecific.

November 9, 2021
·
2 min read
·
Alex Keown